Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial (BMJ Open, 2012)

(untitled) - Preiss, D; Thomas, L; Sun, J; Haffner, S; Holman, R; Standl, E; Leiter, L; Mazzone, T; Rutten, G; Tognoni, G; Martinez, F; Chiang, F; et al.